Companies must understand California Senate Bill 343, aka the Truth in Recycling Law, to meet compliance requirements by the October 4, 2026, effective date.
Ashish R. Talati
Advertisement
Ashish R. Talati is one of the industry’s foremost experts on FDA regulatory matters. He has gained an exceptional reputation for his successful results at the cutting edge of FDA and regulatory law, where he has responded nimbly to changes in the regulatory climate and the marketplace, guiding clients through some of our industries’ most complex issues.
Articles by Ashish R. Talati
Inside FDA’s VQIP, the program that expedites entry for proven, low-risk importers.
What food and dietary supplement brands need to know about extended producer responsibility (EPR).
HHS and FDA consider major changes amid legal and industry pushback.
What do the new "healthy" label claim definitions mean for consumers and food brands?
Australia’s regulatory approach to botanical ingredient changes may inform U.S. companies as they prepare NDI draft guidance comments.
Advertisement
Latest Updated Articles
The GRAS system at a crossroadsApril 10th 2025
Consulting Our Mates Down Under for NDI GuidanceAugust 31st 2016
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
Loren Israelsen to Receive Honorary Doctorate for Role in Shaping US Supplement Regulation
2
Federal Lawsuit Challenges FDA's Refusal to Allow Dietary Supplement Disease-Risk Claims
3
As One Ages, Supplements Become About More Than Nutrition
4
Garden of Life Enters the Clear Whey Protein Category with a Light Texture, Non-GMO Certified Isolate Formula
5